Stockreport

Tempus: Diagnostics Substance, AI Flash [Seeking Alpha]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF TEM's recent large acquisition of Ambry Genetics signals a push for growth, but raises concerns about infrastructure readiness and increasing financial leverage. The [Read more]